EUA
Emergency Use Authorization (EUA)
An Emergency Use Authorization (EUA) is a mechanism by which the United States Food and Drug Administration (FDA) allows the use of unapproved medical products or unapproved uses of approved medical products during a declared emergency. This authorization is intended to facilitate the availability and use of medical countermeasures, including vaccines, treatments, and diagnostic tests, during public health emergencies.
Overview[edit | edit source]
The EUA process is designed to ensure that medical products can be used in emergency situations when there are no adequate, approved, and available alternatives. The FDA evaluates the available scientific evidence to determine whether the known and potential benefits of the product outweigh the known and potential risks.
Criteria for Issuance[edit | edit source]
To issue an EUA, the FDA must determine that:
- There is a serious or life-threatening disease or condition.
- Based on the totality of scientific evidence available, it is reasonable to believe that the product may be effective.
- The known and potential benefits of the product outweigh the known and potential risks.
- There are no adequate, approved, and available alternatives.
Process[edit | edit source]
The EUA process involves several steps: 1. Submission of a request by the product sponsor. 2. Review of the request by the FDA, including evaluation of scientific data. 3. Issuance of the EUA if the criteria are met. 4. Ongoing monitoring and reporting of the product's safety and effectiveness.
Examples[edit | edit source]
The EUA mechanism has been used in various public health emergencies, including:
- The H1N1 influenza pandemic in 2009.
- The Ebola virus outbreak in 2014.
- The COVID-19 pandemic, during which multiple vaccines and treatments received EUAs.
Limitations and Revocation[edit | edit source]
An EUA is not a full approval and is only valid for the duration of the emergency declaration. The FDA can revoke or terminate an EUA if the criteria for issuance are no longer met or if new evidence emerges that changes the risk-benefit analysis.
Related Pages[edit | edit source]
- United States Food and Drug Administration
- COVID-19 pandemic
- Vaccine
- Public health emergency
- Medical countermeasure
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD